Skip to main content

Aging-focused drug company lands new partner, potential half-billion-dollar payout

The "bio-bucks" deal gives the company up to $20 million in upfront and research payouts initially.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.